By Nigam Arora & Dr. Natasha Arora Intelligence to prepare you in advance to act advantageously when a signal to act arrives. Lucrative Opportunities Lucrative opportunities are ahead in personalized cancer vaccines. Several ideas are on our radar at The Arora Report. Cancer Vaccines Are Different A cancer vaccine is
By Nigam Arora & Dr. Natasha Arora Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules
By Nigam Arora & Dr. Natasha Arora To gain an edge, this is what you need to know today. Momo Gurus Spooked Please click here for a chart of Nasdaq 100 ETF (QQQ). Note the following: There is a selloff going on in the early trade as momo gurus are spooked. The
By Nigam Arora & Dr. Natasha Arora LAST DAY: CAPTURE IMMENSE GAINS SUCH AS 2670% — THANKSGIVING SALE — DOUBLE BONUS: ACT NOW TO GET FREE TRIALS To gain an edge, this is what you need to know today. Recency Bias Please click here for a chart of S&P 500
By Nigam Arora & Dr. Natasha Arora There are big rewards from investing in hot sectors. However, individual stocks in hot sectors present significant risks. Fortunately, there is a good way to reap the big rewards and at the same time reduce the risks. This can be accomplished by combining
By Nigam Arora & Dr. Natasha Arora ETFs have less risk than individual stocks. Several ETFs are now providing opportunities as they fall into buy zones. Buy zones are very powerful. This powerful technique is used by billionaires and hedge funds. When a stock dips into the buy zone you
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
The big news is that the vaccine from Pfizer (PFE) and BioNTech (BNTX) has been approved in the U. K. The vaccine is providing many long term investment opportunities and many short term trading opportunities. The Chart Please click here for a chart of vaccine maker Moderna (MRNA). Note the
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market